Class | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
---|---|---|---|---|---|---|---|
Common Stock, par value $0.00001 per share | 1.48M | Oct 22, 2024 | Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc. |